The Hydration Pharmaceuticals Company Limited (ASX:HPC)
Australia · Delayed Price · Currency is AUD 0.0040
0.00 (0.00%)
Aug 11, 2026, 12:54 PM AEST
ASX:HPC Revenue
In the year 2025, The Hydration Pharmaceuticals Company had annual revenue of $2.47M USD, down -22.88%. The Hydration Pharmaceuticals Company had revenue of $946.13K in the half year ending December 31, 2025.
Revenue
$2.47M
Revenue Growth
-22.88%
P/S Ratio
0.57
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.12M AUD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.47M | -733.21K | -22.88% |
| Dec 31, 2024 | 3.20M | -1.10M | -25.48% |
| Dec 31, 2023 | 4.30M | -4.80M | -52.74% |
| Dec 31, 2022 | 9.10M | 2.97M | 48.52% |
| Dec 31, 2021 | 6.13M | 2.37M | 63.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Woolworths Group | 70.28B |
| Coles Group | 45.08B |
| Endeavour Group | 12.12B |
| Treasury Wine Estates | 2.73B |
| TasFoods | 42.35M |
| Eneco Refresh | 17.15M |
| Yowie Group | 16.51M |
| Prestal Holdings | 11.42M |